# Department of Defense - Navy – FDA Inspection, Sep 3, 2010

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/60f38b2f-780e-4114-9aad-0802f3bee05a
Source feed: FDA_Inspections

> FDA inspection 682524 of Department of Defense - Navy, September 03, 2010. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 682524
- Company Name: Department of Defense - Navy
- Inspection Date: 2010-09-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1250935 - 2024-10-03](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/822aeefe-5851-4f86-b20d-37685ebbe783)
- FDA Inspection 1167020 - 2022-03-11
- FDA Inspection 1068540 - 2018-09-20
- FDA Inspection 937758 - 2015-08-06
- [FDA Inspection 847540 - 2013-09-09](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy/cbf07b13-9c45-40ba-bf8a-533130b53480)

Company: https://www.keypedia.com/companies/department-of-defense-navy/3bd0b93e-7977-4b26-ba2c-2f9688483f20

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d